$2.93
+0.01 (+0.34%)
Open$2.97
Previous Close$2.92
Day High$2.98
Day Low$2.91
52W High$9.33
52W Low$3.77
Volume—
Avg Volume600.5K
Market Cap257.06M
P/E Ratio—
EPS$-2.14
SectorPharmaceuticals
Analyst Ratings
Buy
10 analysts
Price Target
+590.1% upside
Current
$2.93
$2.93
Target
$20.22
$20.22
$15.45
$20.22 avg
$24.58
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 473.33M | 386.80M | 70.84M |
| Net Income | -179,766,090 | -132,213,353 | 13.06M |
| Profit Margin | -38.0% | -36.1% | 18.4% |
| EBITDA | -86,822,609 | -67,403,349 | 20.07M |
| Free Cash Flow | — | — | 11.95M |
| Rev Growth | +22.4% | +22.4% | +2.1% |
| Debt/Equity | 0.05 | 0.05 | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |